◼ Archived
Business
🔮 fades ✓
How Pfizer Offset A 95% Decline For One Of Its Drugs
Pfizer has adjusted its 2026 revenue guidance upward following the release of its second-quarter financial results.
Pfizer
8 trends tracked about this subject — the full history, oldest to newest below.
◼ Archived
Business
🔮 fades ✓
Why Pfizer Just Hiked Its Guidance By $500 Million
3 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Business
🔮 fades ✗
Pfizer Covid Pill Revenue Plunges 95%. Why Earnings Are Lifting the Stock Anyway.
Pfizer's stock is rising after beating earnings estimates, despite a 95% plunge in revenue from its Covid pill.
◼ Archived
Business
🔮 fades
Why AstraZeneca Crashed 6%, Leading Two Rivals, Including Pfizer, To Jump
AstraZeneca shares dropped six percent following a heart drug trial setback that simultaneously boosted rival stocks.
◼ Archived
Business
🔮 fades
EXCLUSIVE: US House committee opens investigation into Merck, AbbVie China drug trials
A US House committee has launched an investigation into major pharmaceutical companies regarding the use of clinical trial sites in China.
◼ Archived
Business
🔮 holds
NIKE, Inc. Announces Planned CFO Transition —
8 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Business
🔮 fades
Pfizer’s first new ADC from Seagen acquisition fails phase 3 NSCLC trial
6 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Business
🔮 fades
Closely watched Pfizer lung cancer drug falls short in clinical trial
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.